Cutaneous and ocular adverse reactions in a dog following meloxicam administration

Veterinary Dermatology

Volumn 18, Issue 1, 2007, Pages 45-49

  Niza, Maria M R E ^a   Félix, Nuno ^a   Vilela, Cristina L ^a   Peleteiro, Maria C ^a   Ferreira, Antonio J A ^a  

^a FACULDADE DE MEDICINA VETERINÁRIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ANIMAL LAMENESS; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CORNEA EDEMA; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; DRUG ERUPTION; LEG ULCER; MALE; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CORNEAL EDEMA; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; DRUG ERUPTIONS; LAMENESS, ANIMAL; LEG ULCER; MALE; THIAZINES; THIAZOLES;

ANIMALIA; CANIS FAMILIARIS;

EID: 33846029878     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2007.00566.x     Document Type: Article

References (37)

1. Blain H, Jouzeau JY, Netter P et al. Les anti-inflamatories non steroidiens inhibiteurs sélectifs de la cyclooxygénase 2. Intérêt et Perspectives. La Revue de Medecine Interne 2000; 21: 978-88.
2. Mathews KA. Non-steroidal anti-inflammatory analgesics: a review of current practice. Journal of Veterinary Emergency and Critical Care 2002; 12: 89-97.
3. Laporte JR, Ibanez L, Vidal X et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Safety 2004; 27: 411-20.
4. Deray G. Renal and cardiovascular effects of non-steroidal anti-inflammatory and selective cox 2 inhibitors. La Presse Médicale 2004; 33: 483-9.
5. Ulinski T, Bensman A. Renal complications of non-steroidal anti-inflammatories. Archives of Pediatrics 2004; 11: 885-8.
6. Bircher AJ. Drug-induced urticaria and angioedema caused by non-IgE mediated pathomechanisms. European Journal of Dermatology 1999; 9: 657-63.
7. Babvek S, Celik G, Ozer F et al. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib. Journal of Asthma 2004; 41: 67-75.
8. Jones RD, Baynes RE, Nimitz CT. Nonsteroidal anti-inflammatory drug toxicosis in dogs and cats: 240 cases (1989-90). Journal of the American Veterinary Medical 1992; 210: 475-7.
9. Sellers RS, Senese PB, Khan KNM. Interspecies differences in the nephrotoxicity cyclooxygenase inhibition. Drug and Chemical Toxicology 2004; 27: 111-22.
10. Gomes E, Cardoso MF, Praça F et al. Self-reported drug allergy in a general adult Portuguese population. Clinical and Experimental Allergy 2004; 34: 1597-601.
11. Bukowski JA, Wartenberg D. Comparison of adverse drug reaction reporting in veterinary and human medicine. Journal of the American Veterinary Medical Association 1996; 209: 40-5.
12. Trujillo MJ, Barrio M, Rodriguez A et al. Piroxicam-induced photodermatitis. Cross-reactivity among oxicams. A case report. Allergologia et Immunopathologia 2001; 29: 133-6.
13. Penso D, Roujeau JC, Guillaume JC et al. Toxic epidermal necrolysis after oxicam use. Journal of the American Academy of Dermatology 1986; 14: 275-6.
14. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 20: 123-9.
15. Guillaume JC, Roujeau JC, Revuz J et al. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Archives of Dermatology 1987; 123: 1166-70.
16. Roujeau JC, Kelly JP, Naldy L et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. The New England Journal of Medicine 1995; 333: 1600-7.
17. Nettis E, Di Paola R, Ferrannini A et al. Meloxicam in hypersensitivity to NSAIDs. Allergy 2001; 56: 803-4.
18. Lees P, Landoni MF, Giraudel J et al. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest. Journal of Veterinary Pharmacology and Therapeutics 2004; 27: 479-90.
19. Jones CJ, Streppa HK, Harmon BG et al. In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs. American Journal of Veterinary Research 2002; 63: 1527-431.
20. Mathews KA. Non-steroidal anti-inflammatory analgesics. Indications and contraindications for pain management in dogs and cats. Veterinary Clinics of North America: Small Animal Practice 2000; 30: 783-804.
21. Fowler D, Isakow K, Caulkett N et al. An evaluation of the analgesic effects of meloxicam in addition to epidural morphine/mepivacaine in dogs undergoing cranial cruciate ligament repair. Canadian Veterinary Journal 2003; 44: 643-8.
22. Naisbitt DJ. Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology 2004; 194: 179-96.
23. Shenton JA, Chen L, Uetrecht J. Animal models of idiosyncratic drug reactions. Chemico-Biological Interactions 2004; 150: 53-70.
24. Mason KV. Cutaneous drug eruptions. Veterinary Clinics of North America: Small Animal Practice 1990; 20: 1633-53.
25. Maddison J. Adverse drug reactions. In: Ettinger SJ, Feldman, EC eds. Textbook of Veterinary Internal Medicine, 5th edn. Philadelphia, PA: W. B. Saunders, 2000: 320-5.
26. Mason KV. Therapy for drug eruptions. In: Bonagura JD, ed. Kirk's Current Veterinary Therapy. Philadelphia, PA: W. B. Saunders, 2000; XIII: 556-9.
27. Bircher AJ. Symptoms and danger signs in acute drug hypersensitivity. Toxicology 2005; 209: 201-7.
28. Khoo AKM, Foo CL. Toxic epidermal necrolysis in a burns centre: a 6-year review. Burns 1996; 22: 275-8.
29. Wilkins J, Morrison L, White C. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Dermatologic Clinics 1992; 10: 571-81.
30. Mellor PJ, Roulois AJA, Day MJ et al. Neutrophilic dermatitis and immune-mediated haematological disorders in a dog: suspected adverse reaction to carprofen. Journal of Small Animal Practice 2005; 46: 237-42.
31. Yager JA, Wilcock BP (eds). Vasculitis. In: Color Atlas and Text of Surgical Pathology of the Dog and Cat. Dermatopathology and Skin Tumors. London: Wolfe, 1994: 112-3.
32. Gross TL, Ihrke PJ, Walder EJ et al. (eds) Vascular diseases of the dermis. In: Skin Diseases of the Dog and Cat, 2nd edn. Ames, IA: Blackwell Publishing, 2005: 244-7.
33. Sanchez-Borges M, Capriles-Hulet A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Annals of Allergy, Asthma and Immunology 2000; 84: 101-6.
34. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. Journal of Allergy and Clinical Immunology 2003; 111: 1095-8.
35. Sanchez-Borges M, Capriles-Hulet A. Atopy and NSAID sensitivity. Journal of Allergy and Clinical Immunology 1997; 100: 143-4.
36. Alford SH, Zoratti E, Peterson EL et al. Parental history of atopy disease: disease pattern and risk of pediatric atopy in offspring. Journal of Allergy and Clinical Immunology 2004; 114: 1046-50.
37. Liu X, Beaty TH, Deindl P et al. Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German multicenter atopy study. Journal of Allergy and Clinical Immunology 2004; 113: 489-95.